XML 25 R15.htm IDEA: XBRL DOCUMENT v3.25.2
Regulatory Assets and Liabilities
6 Months Ended
Jun. 30, 2025
Regulated Operations [Abstract]  
Regulatory Assets and Liabilities Regulatory Assets and Liabilities
Regulatory assets and liabilities were comprised of the following as of June 30, 2025 and December 31, 2024:
 Recovery PeriodJune 30, 2025December 31, 2024
Regulatory Assets  
Property-related temporary differences (tax benefits flowed through to customers)Indefinite$178,279 $178,279 
IRMA long-term accounts receivableVarious35,084 46,278 
MWRAM long-term regulatory asset
1 - 2 years
31,308 16,353 
Asset retirement obligations, netIndefinite30,322 28,883 
Other accrued benefitsIndefinite26,702 25,439 
Tank coatingVarious19,753 21,477 
General District Balancing Account receivableVarious9,609 9,393 
Customer Assistance Program and Rate Support Fund accounts receivable
1 year
8,767 9,910 
Incremental Cost Balancing Accounts (ICBA)
1 year
6,708 8,251 
Net WRAM and Modified Cost Balancing Account (MCBA) long-term accounts receivableVarious3,657 3,633 
Recoverable property lossesVarious2,297 2,633 
Other regulatory assetsVarious7,433 6,877 
Total Regulatory Assets$359,919 $357,406 
Regulatory Liabilities  
Cost of removal$503,820 $483,108 
Pension and retiree group health173,964 174,708 
Future tax benefits due to customers104,861 106,184 
Other components of net periodic benefit cost21,194 18,287 
Pension Cost Balancing Account16,048 14,143 
PFAS settlement proceeds8,458 — 
ICBA4,884 6,003 
Health Cost Balancing Account4,341 3,630 
Net WRAM and MCBA long-term payable3,089 3,064 
Conservation Expense Balancing Account2,889 3,294 
Other regulatory liabilities2,109 2,130 
Total Regulatory Liabilities$845,657 $814,551 
Short-term regulatory assets and liabilities are excluded from the above table. The short-term regulatory assets were $63.2 million as of June 30, 2025 and $55.9 million as of December 31, 2024. The short-term regulatory assets as of June 30, 2025 primarily consisted of IRMA, MWRAM, and ICBA receivables. As of December 31, 2024, the short-term regulatory assets primarily consisted of IRMA and MWRAM receivables. The short-term regulatory assets are included in current assets under regulatory balancing accounts on the unaudited Condensed Consolidated Balance Sheets.
The short-term portion of regulatory liabilities was $17.6 million as of June 30, 2025 and $22.6 million as of December 31, 2024. The short-term regulatory liabilities as of June 30, 2025 consisted of Tax Cuts and Jobs Act (TCJA) regulatory liabilities, ICBA regulatory liabilities, PFAS settlement proceeds (see Note 9, Commitments and Contingencies), and IRMA regulatory liabilities. As of December 31, 2024, the short-term regulatory liabilities primarily consisted of TCJA regulatory liabilities, ICBA regulatory liabilities, and IRMA regulatory liabilities. The short-term regulatory liabilities are included in current liabilities under regulatory balancing accounts on the unaudited Condensed Consolidated Balance Sheets.
The PFAS settlement proceeds in the table above represents amounts the Company does not expect to reclassify to Contributions in Aid of Construction (CIAC) in the next 12 months. The Company is required by the Commissions to provide the benefit of the PFAS settlement proceeds to customers through CIAC once PFAS related remediation projects are placed in service. Since the Company is required to provide the benefit of the settlement proceeds to customers, the Company recorded the PFAS settlement proceeds as a regulatory liability and will reclassify them to CIAC once the related projects are placed in service.